文献速递细菌感染、耐药与抗菌药物

新冠疫情暴发后美国门诊抗生素处方适宜性的变化:基于2016-2021年数据的间断时间序列分析

Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.
PubMed 文献 · Clin Infect Dis · 2024-01-01

该研究采用间断时间序列分析,基于Optum去标识化Clinformatics Data Mart数据库2017-2021年数据,纳入37 566 581名参保者,评估2020年3月新冠疫情暴发后门诊抗生素处方适宜性的变化。结果显示,2020年3月至少1次不适宜处方的参保者比例下降0.80个百分点(95%CI -1.09%至-0.51%),随后每月上升0.02个百分点(95%CI 0.01%至0.03%);不适宜处方比例每月上升0.11个百分点(95%CI 0.04%至0.18%)。到2021年12月,该比例已恢复至2019年12月水平。

要点

  • 2020年3月至少1次不适宜抗生素处方的参保者比例下降0.80个百分点(95%CI -1.09%至-0.51%)。
  • 此后该比例每月上升0.02个百分点(95%CI 0.01%至0.03%),不适宜处方比例每月上升0.11个百分点(95%CI 0.04%至0.18%)。
  • 2021年12月至少1次不适宜处方的参保者比例与2019年12月相等。

核心结论

  • 尽管初期下降,至少1次不适宜抗生素处方的参保者比例到2021年12月已恢复至基线水平。
  • 研究结果强调门诊抗生素管理举措持续的重要性。

研究设计与样本

  • 间断时间序列分析,基于Optum去标识化Clinformatics Data Mart数据库(全国商业和Medicare Advantage索赔数据库)。
  • 分析纳入2017-2021年每月参保的儿童和成人配发的抗生素处方,共37 566 581名参保者,其中19 154 059名(51.0%)为女性。
  • 对每张处方,将既往开发的抗生素适宜性分类方案应用于配药当日或前3天内医疗索赔的国际疾病分类第十版临床修改诊断代码。

主要发现

  • 2020年3月至少1次不适宜处方的参保者比例下降0.80个百分点(95%CI -1.09%至-0.51%),随后每月上升0.02个百分点(95%CI 0.01%至0.03%)。
  • 不适宜抗生素处方比例每月上升0.11个百分点(95%CI 0.04%至0.18%)。
  • 2021年12月至少1次不适宜处方的参保者比例与2019年12月相等。
  • 上述变化部分由于整体抗生素配发反弹,部分由于不适宜抗生素处方比例增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No national study has evaluated changes in the appropriateness of US outpatient antibiotic prescribing across all conditions and age groups after the coronavirus disease 2019 (COVID-19) outbreak in March 2020. METHODS: This was an interrupted time series analysis of Optum's de-identified Clinformatics Data Mart Database, a national commercial and Medicare Advantage claims database. Analyses included prescriptions for antibiotics dispensed to children and adults enrolled during each month during 2017-2021. For each prescription, we applied our previously developed antibiotic appropriateness classification scheme to International Classification of Diseases, Tenth Revision, Clinical Modification diagnosis codes on medical claims occurring on or during the 3 days prior to dispensing. Outcomes included the monthly proportion of antibiotic prescriptions that were inappropriate and the monthly proportion of enrollees with ≥1 inappropriate prescription. Using segmented regression models, we assessed for level and slope changes in outcomes in March 2020. RESULTS: Analyses included 37 566 581 enrollees, of whom 19 154 059 (51.0%) were female. The proportion of enrollees with ≥1 inappropriate prescription decreased in March 2020 (level decrease: -0.80 percentage points [95% confidence interval {CI}, -1.09% to -.51%]) and subsequently increased (slope increase: 0.02 percentage points per month [95% CI, .01%-.03%]), partly because overall antibiotic dispensing rebounded and partly because the proportion of antibiotic prescriptions that were inappropriate increased (slope increase: 0.11 percentage points per month [95% CI, .04%-.18%]). In December 2021, the proportion of enrollees with ≥1 inappropriate prescription equaled the corresponding proportion in December 2019. CONCLUSIONS: Despite an initial decline, the proportion of enrollees exposed to inappropriate antibiotics returned to baseline levels by December 2021. Findings underscore the continued importance of outpatient antibiotic stewardship initiatives.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chua KP, Fischer MA, Rahman M, et al. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data. Clin Infect Dis. 2024. PMID: 38648159. doi:10.1093/cid/ciae135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。